Profound Medical Corp. (PROF): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$38.38M

Year ended 2025-12-31

Period ended	Free Cash Flow	Change YoY	Source filing
2025-12-31	-$38.38M	n/a	2026-03-05, From 2025-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Free Cash Flow	Change YoY
Profound Medical Corp. (PROF)	2025-12-31	-$38.38M	n/a
Allurion Technologies, Inc. (ALUR)	2024-12-31	-$42.91M	n/m
Vivos Therapeutics, Inc. (VVOS)	2025-12-31	-$17.60M	n/m
Nephros Inc (NEPH)	2024-12-31	-$555.0K	n/a
Sonoma Pharmaceuticals, Inc. (SNOA)	2026-03-31	-$4.12M	n/m
DarioHealth Corp. (DRIO)	2025-12-31	-$26.08M	n/m
Baird Medical Investment Holdings Ltd (BDMD)	2025-12-31	-$1.39M	n/m
Nexgel, Inc. (NXGL)	2025-12-31	-$1.38M	n/m
WORK Medical Technology Group LTD (WOK)	2025-09-30	$4.91M	n/m

Compare PROF, ALUR, VVOS, NEPH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗